Brief: Enochian Biosciences Announces Acquisition Of Exclusive License For Potential Pan-Coronavirus And Pan-Influenza Inhaled Treatment And Prevention Technology
June 21 (Reuters) - Enochian Biosciences Inc ENOB.O :
* ENOCHIAN BIOSCIENCES ANNOUNCES ACQUISITION OF EXCLUSIVE
LICENSE
FOR POTENTIAL PAN-CORONAVIRUS AND PAN-INFLUENZA INHALED
TREATMENT AND PREVENTION TECHNOLOGY
* ENOCHIAN BIOSCIENCES INC - REQUEST FOR A PRE-INVESTIGATOR
NEW
DRUG MEETING FOR COVID-19 TREATMENT WILL BE SUBMITTED TO FDA IN
NEAR TERM
Source text for Eikon: ID:nGNXbGpCxZ
Further company coverage: ENOB.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Lunai Bioworks
See all newsNASDAQ RESUMED AT 02:16 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:06 PM
Brief: Lunai Bioworks Expands Parkinson's Platform Through Exclusive Tanaist Agreement
Brief: Lunai Bioworks Signs Agreement With Brainstorm Therapeutics
Brief: Lunai Bioworks - Regains Nasdaq Compliance With Minimum $1 Bid Price Rule - SEC Filing